Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
MAIWEIJIAN, First Approved Biosimilar of Denosumab (120mg) in China 2024-04-08 22:00
SeekIn Presents New OncoSeek® Data at the AACR Annual Meeting in San Diego 2024-04-08 20:00
D3 Bio Completes Series A+ Round to Advance Innovative Oncology Pipeline 2024-04-08 15:00
AACR 2024 | Ascentage Pharma Presents Results from Three Studies at 2024 American Association of Cancer Research Annual Meeting 2024-04-08 07:58
I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference 2024-04-05 19:00
IASO Bio Announces U.S. FDA Approval of Investigational New Drug Application for BCMA CAR-T Equecabtagene Autoleucel for Generalized Myasthenia Gravis 2024-04-05 08:00
Huahui Health to Present Preclinical Data of HH018-sesutecan at the 2024 AACR Annual Meeting 2024-04-04 22:00
SYNPET to Showcase Innovative Postbiotic Solutions at Petfood Forum 2024 2024-04-04 01:00
Ractigen Announces First Patient Dosed in the Phase I Clinical Trial of RAG-01 for NMIBC 2024-04-03 20:00
Ascletis Announces Strategic Decisions on FXR agonist ASC42 2024-04-03 17:10
Nagase Viita Receives Highest "Platinum" Rating for Sustainability from EcoVadis 2024-04-03 14:00
I-Mab Announces Closing of the Divestiture of Business Operations in China 2024-04-03 04:01
GC Cell to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024 2024-04-02 23:00
First Patient Dosed in Clinical Trial of YOLT-101 for the Treatment of FH 2024-04-02 20:00
Origin Agritech Provides First Half Revenue Forecast and Updates Advancements in Hybrids and GMO Development 2024-04-02 19:30
Lunit to Showcase 7 Studies at AACR 2024: Unveiling AI Innovations in HER2 Expression-Mutation Analysis and CNTN4 Biomarker Identification 2024-04-01 21:00
Aculys Pharma Announces Appointment of Hidemasa Tanigaki as New CEO 2024-04-01 14:30
LISCure Biosciences receives U.S. FDA Fast Track designation for LB-P8 for the treatment of primary sclerosing cholangitis (PSC) 2024-03-29 21:00
73% CNS ORR! FDA Granted ODD to Utidelone Injectable (UTD1) from Biostar Pharma for the Treatment of Breast Cancer Brain Metastasis 2024-03-29 20:40
Alebund's Innovative Investigational Drug AP303 Receives FDA Orphan Drug Designation (ODD) for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) 2024-03-29 20:00
1 21 22 23 24 25 222